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Abstract 
Background: Sex hormone binding globulin (SHBG), a glycoprotein produced by hepatocytes that transports tes-
tosterone and other steroids in plasma, is a marker for developing metabolic syndrome and T2DM. SHBG is present in 
umbilical cord blood where it may be epigenetically regulated. This study was conducted to investigate whether the 
fetal environment, based on maternal pre-pregnancy weight, pregnancy weight gain or smoking during pregnancy, 
influence SHBG in newborns.
Methods: Maternal and newborn characteristics and SHBG levels and other variables were measured in cord and day 
2 heel-stick blood samples in 60 healthy full-term singleton babies (31 F, 29 M).
Results: SHBG levels varied nearly fivefold among male and female newborns and were unrelated to sex, neonatal 
adiposity, determined by the Ponderal index and skinfold thickness, nor TNF∝ in cord blood. There were also no sta-
tistically significant associations between pre-pregnancy weight or pregnancy weight gain and newborn SHBG levels. 
However, cord blood SHBG was higher and insulin levels were lower when mothers were smokers, but normalized by 
day 2.
Discussion: While SHBG levels are low in obese children and adults, and portend the development of metabolic 
syndrome and T2DM, our study of healthy babies born to normal women, found no connection between maternal 
obesity or newborn adiposity and SHBG levels in newborns. Insofar as women who smoked during pregnancy were 
thinner and had lower cord blood insulin levels than nonsmokers, higher SHBG in their newborns at birth might have 
been due to insulin sensitivity, or perhaps to an effect of smoking on placental gene expression.
Conclusions: Factors other than maternal weight and pregnancy weight gain appear to be the major determinants 
of SHBG in newborns. Higher SHBG levels when mothers smoke during pregnancy may contribute to overweight 
beginning later in childhood. Whether newborn SHBG levels predict the development of overweight and metabolic 
syndrome remains to be determined.
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Background
Sex hormone binding-globulin (SHBG) is a circulat-
ing glycoprotein secreted predominantly by hepatocytes 
which binds certain sex steroids, including testosterone, 
dihydrotestosterone, and estradiol, and regulates their 
entry into target cells [1]. The SHBG gene, located on 
chromosome 17 (17p13-1p12), and its protein product 
are regulated by genetic factors, nutritional cues and 
various hormones. Notably, SHBG levels in children and 
adults are inversely related to adiposity and to insulin 
resistance [2]. SHBG levels are reduced in children born 
at low birth weight [3], in teenage children with the meta-
bolic syndrome [4], and in pre-pubertal children whose 
parents have the metabolic syndrome [5]. Moreover, low 
levels of SHBG in adolescence predict adiposity and insu-
lin resistance in adulthood [6, 7]. Thus there is increasing 
research on SHBG.
SHBG is present in cord blood where levels vary among 
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differ by sex [9, 10] or race [11]. Cord blood SHBG lev-
els were inversely related to cord blood insulin in a com-
bined population of healthy pregnant women and those 
with gestational diabetes, but mean levels did not differ 
between the two groups [12]. Cord blood SHBG levels 
were higher when pregnant women with PCOS were 
treated with metformin than with placebo [13]
The concept of fetal programming has been gaining 
momentum with increasing evidence that the intrauter-
ine milieu influences disease development later in life 
[14]. Children born to obese mothers are more likely to 
become obese [15], and excessive maternal pregnancy 
weight gain results in higher birth weight infants, which, 
in turn, is associated with subsequent obesity and obe-
sity-related negative health outcomes [16]. Cigarette 
smoking during pregnancy is associated with reduced 
fetal growth and an increased risk for intrauterine growth 
retardation [17, 18], with increased obesity as early as age 
5 years [19], and with increased diabetes risk when babies 
reach adulthood [20]. In rats, prenatal nicotine exposure 
produced a marked hypertrophy in adipocytes, and a 
decrease in pancreatic islet size, along with glucose intol-
erance and insulin resistance in adulthood [21]. Newborn 
babies exposed in utero to tobacco smoke have increased 
cord blood concentrations of prolactin and growth hor-
mone [22] and cortisol [23], but no studies have exam-
ined SHBG.
In this study, we sought to determine the impact of the 
intrauterine environment based on maternal pre-preg-
nancy weight and pregnancy weight gain, and maternal 
smoking status, as well as newborn adiposity on the vari-
ability in SHBG among neonates born to healthy moth-
ers. Since SHBG is expressed in the placenta, and the 
mRNA is reduced in mothers with gestational diabetes 
[24], we studied SHBG in neonates on day 2 as well as 
in cord blood. This research begins to explore the over-
all hypothesis that SHBG levels in the fetus and newborn 
are partly under genetic control but are also regulated 
by the intrauterine environment, and may contribute to 
and predict the development of adiposity, metabolic syn-
drome and diabetes as children grow older.
Methods
We evaluated mothers without pre-eclampsia, diabetes 
or complications during pregnancy who gave birth to sin-
gleton babies born by vaginal delivery. Informed consent 
was obtained in accordance with a protocol approved 
by the Institutional Review Boards of the University of 
Louisville and Louisville University Hospital. Babies had 
an Apgar score of 7 or greater at 5  min, and no appar-
ent congenital anomalies. 66 mothers provided informed 
consent but data were complete for 60 women who gave 
birth to 31 girls and 29 boys. For 6 babies, blood samples 
were lost and not analyzed. There were 24 whites, 25 
blacks, and 17 babies who were mixed race or other. 
Maternal pre-pregnancy weight was obtained by chart 
review or by recall. Gestational weight gain was calcu-
lated as the difference between the last weight measured 
before delivery and the pre-pregnancy weight. Placental 
weight was measured after removal of the umbilical cord 
and membranes. Mothers were classified as smokers if 
they answered ‘yes’ to the question, “have you smoked 
during your pregnancy?” All participants denied use of 
alcohol during pregnancy.
Birth weight (gm) and length (cm) were determined, 
and babies were re-examined on day 2 of age at which 
time the subscapular skin fold (SSF) and triceps skin fold 
(TSF) thickness were determined by a pediatrician (LW) 
using a Harpenden caliper. The Ponderal index, [(weight 
in gm) × 100/(length in cm)3] was calculated as a meas-
ure of infant adiposity.
Venous cord blood was collected from a clamped seg-
ment of the umbilical cord at delivery, and heel-stick 
blood samples were obtained during the physical exami-
nation on day 2. Glucose was measured using a glucom-
eter (StatStrip blood glucose meter, Nova Biomedical, 
Waltham, MA, USA). Samples were centrifuged and 
stored at −20 °C for assay. SHBG and insulin were meas-
ured using ELISA kits from Alpco (Salem, NH, USA). 
TNF∝ was measured using the Quantikine HS ELISA 
Human TNF alpha assay (R and D Systems, Minneapolis, 
MN, USA).
Statistical analyses used t tests to compare group 
means and linear regression to evaluate associations of 
SHBG levels with continuous covariates. All analyses 
were conducted using STATA data analysis and statistical 
software (College Station, TX, USA). Effect modification 
by smoking was modeled using multiplicative interaction 
terms in regression analysis. Multiplicative interaction is 
the most common type of effect modifications; additive 
interaction, which is rarer, was not modeled.
Results
SHBG levels in cord blood ranged from 20.5 to 
90.8  nmol/L, and in the heel stick sample on day 2 
from 15.2 to 80.3  nmol/L. Overall there was no signifi-
cant difference between the mean (±SD) levels in boys 
(45.1  ±  18.9) and girls (39.9  ±  10.7  nmol/L) in either 
cord blood or the samples taken on day 2 (40.4 ± 15.0 vs 
37.2 ± 14.1 nmol/L).
Results for women who smoked during pregnancy 
(n  =  14) and their babies are compared to nonsmokers 
(n =  46) in Table  1. Mothers who smoked were thinner, 
and their cord blood had lower insulin and higher SHBG 
levels than the non-smokers. The average birth weight of 
babies born to smokers was 93 g lower, which was 4.8 % 
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less (p = NS), than for nonsmokers while placental weights 
were similar. One baby in the former group and two in 
the latter group were low birth weight (<2500  g). By day 
2, SHBG levels in babies born to smokers declined to the 
levels of nonsmokers. Figure 1 shows the individual values 
for SHBG in smokers and non-smokers. In contrast to the 
babies born to smokers, SHBG levels in the newborns of 
non-smokers were similar in cord blood and on day 2. 
Figure  2 shows the relationship between cord blood 
insulin and SHBG. There was a statistically significant, 
inverse association of cord blood insulin with SHBG in 
smokers (R2 = 0.54; p < 0.003), but no association in non-
smokers (R2 = 0.03; p = 0.26); hence, there was a statis-
tically significant interaction between smoking and the 
association of cord insulin with SHBG (p =  0.04). Mul-
tiple regression analysis suggested that the main effect 
of smoking on cord blood SHBG and the interaction of 
smoking with cord blood insulin were independent of 
pre-pregnancy weight, pregnancy weight gain, race, pla-
cental weight, birthweight and skinfold thickness. This 
finding suggests that maternal smoking modifies the 
relationship between insulin and SHBG in cord blood 
regardless of measures of maternal or infant body size 
and adiposity.
TNF∝ was reported to suppress SHBG production in 
HepG2 hepatocarcinoma cells by decreasing the level of 
the transcription factor HNF4∝ [25]. In this study, cord 
blood TNF∝ levels were not different between smokers 
Table 1 Clinical characteristics and  hormone values 
in  women who smoked during  pregnancy and  nonsmok-
ers, and their offspring
Results are Mean ± SD
a Glucose levels were available for 42 subjects
Variable Smokers (n = 14) Nonsmokers 
(n = 46)
p value
SHBG in cord blood 
(nmol/L)
48.0 ± 11.4 39.7 ± 13.7 0.04
Cord blood insulin 
(U/L)
2.0 ± 0.71 3.1 ± 1.94 0.045
Cord blood TNF∝ 
(pg/mL)
6.92 ± 2.54 7.68 ± 4.22
Cord blood glucose 
(mmol/L)a
6.32 ± 1.10 5.88 ± 1.81
SHBG day 2 (nmol/L) 40.4 ± 20.0 38.4 ± 15.3
Birth weight (g) 3032 ± 402 3184 ± 401
Placenta weight (g) 487 ± 83 480 ± 111
Maternal age (years) 25.7 ± 4.7 26.7 ± 6.2
Maternal pre-preg-
nancy wt (kg)
60.9 ± 13.0 72.3 ± 19.1 0.03
Pregnancy weight 
gain (kg)
14.3 ± 7.4 14.3 ± 9.3


































Fig. 1 Levels of SHBG in cord blood and heel stick blood in babies 
born to mothers who smoked during pregnancy and those who did 
not smoke. Open symbols are boys and filled symbols are girls. Of the 
14 smokers, the result on day 2 was lower in 11. Mean (±) SD values 
are also shown. The difference between the two samples for babies 
whose mothers smoked was significantly different when analyzed by 
paired t test (p = 0.0135)
Insulin (mU/L)






















Fig. 2 Scatterplot showing the relationship between the levels of 
insulin and SHBG in cord blood samples among male and female 
newborns by maternal smoking status. Interrupted line indicates the 
regression plot for smokers (R2 = 0.54; p < 0.003), and the solid line is 
for non-smokers. (R2 = 0.03; p = 0.26)
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and nonsmokers, and were unrelated to cord blood 
SHBG (R2 = 0.03).
We next performed linear regression analysis to deter-
mine whether anthropometric variables were associated 
with SHBG (Fig.  3). Neither pre-pregnancy weight nor 
pregnancy weight gain was an important determinant of 
SHBG in cord blood. While there was a suggestion for an 
interaction between smoking and pregnancy weight gain 
with cord blood SHBG, it was not statistically significant 
(p = 0.30). Moreover, the apparent inverse association of 
pregnancy weight gain with cord blood SHBG in smok-
ers (R2 = 0.20, p = 0.11) was not altered by adjustment 
for insulin (R2  =  0.198, p  =  0.13). Similarly, the asso-
ciation of cord blood SHBG with pre-pregnancy weight 
(R2  =  0.23, p  =  0.08) was only slightly diminished by 
adjustment for insulin (R2 =  0.19, p =  0.13). There was 
no association between pregnancy weight gain and day 2 
heel-stick blood samples in either smokers or nonsmok-
ers. In agreement with previous results [26], birth weight 
was positively related to placental weight (R2  =  0.35; 
p < 0.01; not shown). There was no significant relation-
ship (p > 0.05) between SHBG on day 2 with either sub-
scapular skinfold thickness, triceps skinfold thickness or 
flank skinfold thickness (not shown), birthweight, or the 
Ponderal index, a measure of fetal growth and nutrition 
(Fig. 4).
Discussion
The gestational period is a crucial time of growth, devel-
opment and physiological change in the fetus. It is a 
window of opportunity for intervention via maternal 
nutrition and/or physical activity that may induce favora-
ble changes in the in utero environment that will influ-
ence the lifelong risk for metabolic syndrome and T2DM.
The level of SHBG in plasma is known to be under 
genetic as well as hormonal and nutritional control. 
Because SHBG is inversely related to BMI beginning 
in childhood, and is a marker for insulin resistance and 
the risk for developing T2DM [1], we hypothesized that 































































































Fig. 3 Scatterplots showing the relationship between pre-pregnancy weight and maternal weight gain during pregnancy to SHBG levels in cord 
blood and in day 2 heel stick samples by maternal smoking status. Interrupted line indicates the regression plot for smokers and the solid line is for 
non-smokers
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metabolic status, and might be related to the newborn’s 
Ponderal index or skin fold thickness, or might correlate 
with maternal obesity or pregnancy weight gain. SHBG is 
expressed in the placenta which might contribute to the 
level in cord blood; therefore we show, for the first time, 
SHBG levels in heel-stick blood samples on day 2 as well 
as in cord blood samples. We recognize, however, that 
due to a long circulating half-life [27], a small amount 
of placental SHBG might remain in fetal blood on day 2. 
SHBG levels in both cord blood and heel stick blood var-
ied among individuals by fivefold, did not differ by sex, 
and were unrelated significantly to these anthropometric 
descriptors. In a previous study, SHBG levels were lower 
in babies born in Boston than in Shanghai where mothers 
had lower BMI and less pregnancy weight gain [28].
Instead, we discovered higher levels of SHBG in cord 
blood of maternal tobacco smokers that normalized by 
age 2 days. It is estimated that 4–25 % of women world-
wide continue to smoke during pregnancy, and 24  % of 
our new mothers viewed themselves as smokers. Mater-
nal cigarette smoking is known to be pathogenic includ-
ing increasing the risk for prematurity and low birth 
weight as well as obesity and type 2 diabetes in later life 
[18]. Mothers who smoked were thinner, and their cord 
blood insulin concentrations were lower, than for non-
smokers. BMI has been higher in maternal smokers than 
nonsmokers in some studies but not in others [29]. SHBG 
and insulin levels in cord blood were inversely related 
among mothers who smoked, but not among non-smok-
ers, suggesting that smoking induces or enhances the 
relationship between insulin and SHBG. This finding has 
not been reported previously.
Higher SHBG levels in cord blood of smoking moth-
ers may have resulted from indirect or direct effects of 
smoking on the fetal liver. To what extent higher SHBG 
levels in the cord blood of smokers was impacted by 
their thinness and lower insulin levels is not known. In 
a previous study, insulin and SHBG levels in cord blood 
were likewise inversely related among mothers with ges-
tational diabetes [9]. While there is a substantial amount 
of data supporting an association between higher insulin 
levels and low levels of SHBG [30], no cellular mecha-
nism has been established for this association, and more 
recent experiments using hepatocarcinoma cells have 
challenged the idea that insulin itself is a regulator of 
SHBG expression [31]. As much as 70  % of the blood 
supply to the fetal liver is from the umbilical vein, result-
ing in exposure to high concentrations of xenochemicals 
from the maternal circulation. In this regard, maternal 
smoking was found to affect the expression level of a vari-
ety of genes in liver samples from fetuses from women 
undergoing second trimester elective pregnancy termina-
tion [32, 33]; however, no information was provided for 
SHBG.
Higher SHBG levels in cord blood of smokers might 
instead reflect SHBG of placental origin [24]. Placen-
tal DNA methylation patterns are altered with maternal 
smoking [34], and the expression level of placental genes 
related to coagulation and vasculogenesis is increased 
while the expression of cell adhesion-related genes is 
decreased; however, SHBG was not among the placental 
genes noted to be differentially expressed [35]. Although 
no studies have examined the effects of added insulin on 
placenta SHBG expression, SHBG mRNA levels were 
lower in placentas from hyperinsulinemic women with 
gestational diabetes [24]; so it is possible that elevated 
SHBG in cord blood in smokers in inverse relation to 
insulin levels was partly from placenta.
Several studies have linked higher maternal pre-preg-
nancy weight and greater gestational weight gain to 
adverse perinatal health outcomes including preterm 
birth, low-birth weight and macrosomia [36]. Moreover, 
maternal obesity has been associated with offspring with 
an increased risk for obesity lifelong as well as insulin 
resistance, hypertension and dyslipidemia, [37]. Higher 
circulating levels of inflammatory cytokines, insulin 
resistance and hyperinsulinemia, and dyslipidemia may 
cause permanent changes in the developing fetus. In 
one study of women from China, cord blood SHBG lev-
els were lower among babies born to overweight moth-
ers, most of whom had gestational diabetes [38]. In the 
current study, we found no inverse relationship between 
maternal obesity or weight gain during pregnancy with 
SHBG in the newborns of nondiabetic women, and no 
relationship between SHBG and neonatal markers of 
obesity including skin fold thickness and the Ponderal 
index, or to cord blood levels of the cytokine TNF∝. Thus 
Ponderal Index























Fig. 4 Relationship between the Ponderal index and SHBG in new-
born babies on day 2 by maternal smoking status
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lower SHBG levels born to overweight diabetic women, if 
confirmed, might be due to diabetes rather than obesity. 
Moreover, genetic factors may contribute to the substan-
tial variation in SHBG among newborns.
Limitations of this study include a relatively small sam-
ple size, especially for women who smoked during preg-
nancy, the reliance on recall for pre-pregnancy weight, 
and the broad definition of smoking during pregnancy. 
Denial of smoking would result in misclassification of 
smokers as non-smokers. Multiple hormonal and genetic 
factors are known to influence plasma SHBG levels 
in adults, but were not studied due to lack of sufficient 
sample volumes. Finally, intrahepatic fat was reported to 
be higher in infants born to obese mothers with gesta-
tional diabetes compared to infants of nondiabetic nor-
mal-weight mothers [39], and hepatic fat is known to be 
inversely associated with SHBG [40]; however, hepatic fat 
was not measured in the newborns in this study.
Maternal smoking is one of many factors associated 
with low birth weight and a subsequent increase in the 
risk for obesity in childhood and adult life. SHBG levels 
in low birth-weight boys were not statistically different 
from controls at age 2–3 months [41], but by age 8 years 
were lower in low birth weight girls [3], and low SHBG 
was found with obesity in both sexes by age 6–9 years [42] 
suggesting that the link between low SHBG and obesity is 
acquired at a young age. While low SHBG in older chil-
dren and adults is a recognized marker of insulin resist-
ance and hepatic steatosis, longitudinal studies are needed 
to determine whether SHBG levels at birth predict meta-
bolic status later in life, and could be used as a marker for 
early interventions. Studies using human adult liver indi-
cate that the major determinant of hepatic SHBG expres-
sion is the level of the transcription factor HNF4∝, a key 
regulator of hepatocyte function [43]. Whether SHBG is 
an indicator of HNF4∝ activity in fetal liver, or itself plays 
a direct role in fetal metabolism and subsequent meta-
bolic health outcomes remains to be determined.
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